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Abstract Strict quality control mechanisms within the mam-
malian endoplasmic reticulum act to prevent misfolded and
unprocessed proteins from entering post-endoplasmic reticulum
(ER) compartments. Following translocation into the ER lumen
via the Sec61p translocon, nascent polypeptide chains fold and
are modified in an environment that contains numerous
chaperones and other folding mediators. Recently it has emerged
that polypeptides failing to acquire the native state are re-
exported from the ER to the cytosol for ultimate degradation by
the proteasome ubiquitin system, apparently mediated again via
Sec61p. Substrates for this degradation pathway include proteins
destined to become glycosyl phosphatidylinositol (GPI)-an-
chored, but which fail to be processed and retain the C-terminal
GPI signal peptide. In order to characterise this process we have
used a model GPI-anchored mutant protein, prepro mini human
placental alkaline phosphatase (PLAP) W179, which cannot be
processed efficiently on account of being a poor substrate for the
transamidase which cleaves the GPI signal peptide and adds the
GPI anchor in a coupled reaction. In vitro transcription,
translation and translocation into canine pancreatic microsomes
resulted in ER-targeting signal sequence cleavage and formation
of prominiPLAP in the ER lumen. We were able to show that
prominiPLAPW179 could be exported from the microsomes in a
time-dependent manner and that release requires both ATP and
cytosol. Export was not supported by GTP, indicating a
biochemical distinction from glycopeptide export which we
showed recently requires GTP hydrolysis. The process was not
affected by redox, unlike several other GPI-anchored model
proteins. These data demonstrate that misprocessed proteins can
be exported in vitro from mammalian microsomes, facilitating
identification of factors involved in this process. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
In eukaryotic cells, endoplasmic reticulum (ER)-targeted
proteins are translocated into the ER lumen cotranslationally
or posttranslationally via the Sec61p translocon complex.
During or shortly after translocation various processes, in-
cluding removal of signal peptide, disul¢de bond formation,
addition of a glycosyl phosphatidylinositol (GPI) anchor
and N-glycosylation, are initiated and the protein enters
into one of various folding pathways [1,2]. A stringent quality
control machinery at the ER level ensures that misfolded and
unassembled proteins are retained in the ER lumen by molec-
ular chaperones and then exported back to the cytosol where
they are degraded by the ubiquitin/proteasome systems [1,3^
8]. Interestingly, these proteins are exported via the same
channel through which they were originally imported into
the ER, namely the Sec61p translocon [9,10]. Allowing mis-
folded proteins and folding intermediates into the Golgi
complex or other post-ER secretory pathway compartments
can lead to competition with true secretory cargo for the
various modi¢cation and tra⁄cking processes with poten-
tial deleterious consequences. Recent data suggest that the
calnexin component of the quality control system is able to
sense subtle di¡erences between conformation of folding pro-
teins [11].
The GPI anchor, a complex glycolipid, is the sole mecha-
nism of cell membrane attachment for many proteins in most
if not all eukaryotic cells [12,13]. GPI attachment requires
translocation of the nascent polypeptide chain across the
ER membrane followed by cleavage of a C-terminal signal
between two small side chain amino acids 10^12 residues N-
terminal of the hydrophobic domain and its replacement, in a
coupled process, by a preformed GPI moiety [13]. When GPI
anchor addition is prevented by mutation of the cleavage site,
instead of rapid export of the protein to the cell surface the
protein fails to be included into ER transport vesicles [14], is
retained and in common with other misfolded proteins is de-
graded by the ubiquitin/proteasome system [8]. GPI anchoring
has been e⁄ciently reproduced in an in vitro system [13] using
an engineered model protein miniPLAP (mPLAP) based on
the human placental alkaline phosphatase (PLAP). Prepro-
mPLAP is devoid of N-glycosylation sites, the catalytic site
and most cysteine residues [13]. A mutant form of prepro-
mPLAP (S179W substitution) was in vitro translated and
translocated into the ER, its N-terminal signal sequence was
cleaved o¡ to give promPLAPW179 but it was not further
processed by the transamidase and did not receive a GPI
anchor [15]. We used this system to study the quality control
of GPI-anchored proteins in canine pancreatic microsomes.
We show that mPLAPW179 indeed enters the ER but does
not become GPI-anchored. Most signi¢cantly, we ¢nd that
promPLAPW179 is exported out of the ER in an ATP-, cy-
tosol- and time-dependent manner.
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2. Materials and methods
2.1. Materials
Nuclease-treated rabbit reticulocyte lysate, amino acid mixture mi-
nus methionine, canine microsomal membranes, signal sequence con-
trol (prolactin) mRNA, RNasin ribonuclease inhibitor and nuclease-
free water were all supplied by Promega. mPLAP pGEM plasmids
were the kind gift of Dr E. Medof (University of Cleveland, OH,
USA). Radiolabelled compounds were from ICN Pharmaceuticals.
Restriction enzymes were from Stratagene and other reagents were
either from Sigma or from other suppliers and of the highest available
grade.
2.2. Preparation of mPLAP mRNA
pGEM mPLAP plasmids (200 Wg) were digested with HindIII. Di-
gestions were shown to be complete by analysis of an aliquot by
agarose gel electrophoresis. Plasmid DNA preparations were rendered
RNase-free by ethanol precipitation following phenol extraction
(twice) and resuspended in diethyl pyrocarbonate-treated water.
mRNA was synthesised using a RiboMax kit (Promega). A typical
250 Wl reaction mixture contained 50 Wl of SP6 transcription
5Ubu¡er, 50 Wl of a mixture of rNTPs (25 WM ATP, CTP, GTP,
UTP), 125 Wl linear DNA template (50^100 Wg total) plus nuclease-
free water and 25 Wl of enzyme mix (SP6). The reaction mix was
incubated at 37‡C for 4 h. Following in vitro transcription, the
RNA was DNase-treated and RNA extracted by the addition of
one volume of TE-saturated (pH 4.5) phenol:chloroform (25:24).
The solution was vortexed for 1 min and then spun in a microfuge
for 2 min. The upper aqueous phase was transferred to a fresh tube
and one volume of chloroform was added. This was vortexed and
spun as before. The resulting aqueous phase was again transferred
to a fresh tube and the RNA ethanol precipitated. The RNA samples
were stored in aliquots at 385‡C until subsequent use.
2.3. Translation/translocation/processing of mPLAP
Cell-free translation reactions were conducted using the rabbit re-
ticulocyte lysate as described by Pelham and Jackson [16] with the
addition of canine pancreatic microsomal membranes for processing.
Typically a 25 Wl reaction mixture contained, in the following order,
1.5 Wl of nuclease-free water, 3 Wl of mRNA (either mPLAPS179 or
mPLAPW179 mRNA), 1 Wl of RNasin ribonuclease inhibitor, 12.5 Wl
of the nuclease-treated lysate, 1 Wl of a mixture of amino acids minus
methionine (1 mM), 2.5 Wl of canine microsomes and 4 Wl of
[35S]Trans-Label (ICN). In order to compare the unprocessed form
of the protein with the processed form, control translation reactions
were carried out in the absence of microsomes. The mRNA was de-
natured at 65‡C for 3 min in nuclease-free water and immediately
cooled on ice prior to the addition of the other components. Reaction
mixtures were then incubated at 30‡C for 90 min. Prior to analysis by
SDS^PAGE or further assays, the samples were typically centrifuged
at 20 000Ug at 4‡C for 10 min in order to pellet the membranes. The
membranes were then resuspended in 25^70 Wl of B88 reaction bu¡er
(20 mM HEPES, pH 7.4, 150 mM potassium acetate, 250 mM sorbi-
tol, 5 mM magnesium acetate), and 5 Wl aliquots of this were taken
for assay or analysis.
2.4. Protease protection assay
Proteinase K from a stock solution was added to a ¢nal concen-
tration of 100 Wg/ml and incubated on ice for 30 min. The digestions
were quenched by the addition of phenylmethylsulphonyl £uoride
(PMSF) to a ¢nal concentration of 4 mM. The treated samples
were immediately heated in SDS^PAGE sample bu¡er at 95‡C and
analysed by SDS^PAGE.
2.5. Export assay
Reaction mixtures were prepared for export assays in a total of 25
Wl and contained 12.5 Wl B88 bu¡er, 5 ml of resuspended membranes,
5 Wl cytosol and ¢nally 2.5 Wl of 10UATP regenerating mix (10 mM
ATP, 400 mM creatine phosphate, 2 mg/ml creatine kinase, 500 WM
GDP-mannose [17]). Controls included reactions without ATP mix,
without cytosol and full reaction incubated on ice for the duration of
the assay. For some reactions GTP was added to a concentration of
10 WM. Reactions were incubated at 32‡C for a speci¢ed period of
time after which samples were centrifuged for 10 min at 20 000Ug at
2‡C for 10 min. The supernatants were removed, representing the
cytosolic fractions, and placed in fresh tubes. The pellets (membrane
fractions) were resuspended in 20 Wl of phosphate-bu¡ered saline.
Equivalent aliquots of the samples were analysed by SDS^PAGE.
2.6. Gel electrophoresis and autoradiography
The denatured proteins were fractionated on 15% SDS polyacryl-
amide mini-gels according to Laemmli [18]. After SDS^PAGE, the
gels were ¢xed and stained with Coomassie blue (0.1% brilliant
blue, 50% methanol, 10% acetic acid and 40% distilled water) for 1 h
then destained. Destained gels were then soaked with En3Hance
(NEN Life Science Products). Following impregnation with
En3Hance, the gels were dried and exposed to ¢lm (Kodak Biomax
¢lm) for 1^4 days at 385‡C. Autoradiographs were digitised using a
Scanmaker II scanner and analysed using NIH-Image.
2.7. Preparation of rat liver cytosol
Cytosol used was prepared from rat liver as previously described
[19,20]. Brie£y, rat livers obtained from Harlan Sera-Lab Ltd.
(Loughborough, UK) were homogenised in B88 bu¡er (20 mM
HEPES, pH 7.4, 150 mM potassium acetate, 250 mM sorbitol,
5 mM magnesium acetate) containing 1 mM PMSF and 1 mM dithio-
threitol (DTT). The homogenate was cleared of large cell debris by
centrifugation at 8000Ug for 10 min and the supernatant was sub-
jected to a 100 000Ug centrifugation for 40 min. The supernatant was
gel-¢ltered through a Sephadex G-10 column into B88 bu¡er contain-
ing 1 mM DTT. The cytosol was stored at 385‡C in 100 Wl aliquots at
35 mg/ml protein. A fresh aliquot was used for each experiment.
3. Results and discussion
3.1. MiniPLAPW179 mutant protein is imported in vitro into
canine pancreatic microsomes but not GPI-anchored
We ¢rst wished to ensure that the mPLAPW179 did not
become GPI-anchored by our canine microsome system. To
achieve this we compared the translation products of
mPLAPW179 and mPLAPS179 in vitro transcribed mRNAs.
The mPLAPS179 variant is a good substrate for transamidase
and is GPI-anchored by the in vitro system (Fig. 1A) [13]. We
performed translation reactions in the presence or absence of
microsomes and the resulting proteins were analysed by SDS^
PAGE and autoradiography. In the absence of microsomes
prepromPLAPW179 was the sole translation product detected
from the corresponding mRNA (Mr V28 kDa) (Fig. 1B)
indicating translation but no further processing. However, in
the presence of microsomes this species was converted quan-
titatively to the pro form indicating N-terminal signal se-
quence cleavage (Fig. 1B; Mr V27 kDa). Signi¢cantly, no
GPI-anchored form of mPLAPW179 can be seen which is
in agreement with previous work [15]. As a control, L-lactam-
ase mRNA was translated under the same conditions and
shown to be translocated into microsomes and signal peptide
processed e⁄ciently (Fig. 1B). A small amount of a lower
molecular weight species was also detected which was pro-
cessed in the presence of microsomes suggesting that it is a
form derived from prematurely terminated translation. When
mPLAPS179 was similarly translated in the presence of micro-
somes, it was quantitatively N-terminally processed and par-
tially GPI-anchored (not shown and Fig. 1C). To demonstrate
that the S and W mPLAP species had been translocated to the
interior of pancreatic microsomes, we performed a protease
protection assay following translocation. Translation reac-
tions (with or without microsomes) were treated with protein-
ase K at 100 Wg/ml on ice for 30 min [21] and products then
analysed by SDS^PAGE. In the absence of microsomes both
mPLAPS179 and mPLAPW179 were fully susceptible to pro-
teinase K treatment (Fig. 1C) whereas in the presence of mi-
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crosomes the translocated chains were protected; these corre-
spond to both the pro and mature forms of mPLAPS179 and
the pro form of mPLAPW179. This con¢rms that the signal
peptide-processed mPLAP polypeptides are indeed within the
microsome lumen and that the W179 mutant behaves as pre-
dicted and is not processed by GPI addition.
3.2. Reconstitution of export of mPLAPW179
mPLAPS179 was only partially GPI-anchored in canine
pancreatic microsomes with the consequence that the majority
of this translation product could potentially enter the re-ex-
port system. This mixed population of species is unsuitable for
further analysis as a control construct. Hence, as we were
interested in the fate of the mutant mPLAPW179 due to
lack of a GPI anchor, we focused our studies exclusively on
this protein. Previous in vivo studies on a mutant GPI-an-
chored protein derived from human growth hormone
(hD28) implicated the ER-associated degradation (ERAD)
system for its disposal as the protein half-life was increased
by proteasome inhibitors and was decreased by ubiquitination
[8]. Studies on in vitro systems in yeast have demonstrated
that ERAD requires ATP and cytosol for reconstitution [6].
Addition of proteasome inhibitors to cells expressing ERAD
substrates results in accumulation of mutant protein in the
cytosol [22], and it has recently been shown that ERAD sub-
strates are re-exported to the cytosol via the Sec61p pore
complex [9,10]. Using the above information, assays were con-
structed in order to reconstitute the process of ERAD in this
in vitro system using mPLAPW179 as substrate. We used the
release of mPLAPW179 polypeptide into soluble form as a
readout for export. Once the translation/processing reactions
had been completed, the pelleted microsomal membranes were
resuspended in B88 bu¡er, and aliquots incubated under var-
ious conditions (see Section 2 for details). After incubation for
90 min at 32‡C, the samples were again centrifuged at
20 000Ug for 10 min. The supernatant (cytosolic fraction)Fig. 1. Processing of mPLAP by canine pancreatic microsomes. A:
Schematic presentation of processing of mPLAP. PrepromPLAP (28
kDa) has both an N-terminal signal peptide for directing insertion
into the ER and a C-terminal signal peptide for transamidase cleav-
age and addition of the GPI anchor. The N-terminal signal is re-
moved cotranslationally by signal peptidase to give the pro form
(27 kDa) which for mPLAPSer179 is processed by the transamidase
to the mature GPI-anchored form. mPLAPW179 is not processed
beyond the pro form and therefore is expected to be handled by the
ERAD system. B and C: Cotranslational processing and transloca-
tion of mPLAP and L-lactamase into canine pancreatic microsomes.
B: mPLAPW179 and L-lactamase mRNA were translated with a
rabbit reticulocyte lysate system in the presence or absence of canine
pancreatic microsomes. In the absence of microsomes prepromPLAP
(Mr V28 kDa) accumulated whereas in the presence of microsomes
it was quantitatively processed by the signal peptidase to prom-
PLAP. L-Lactamase also shows the signal peptide cleavage of the
prepro to the pro form. mPLAPS179 mRNA gave similar results to
mPLAPW179 except that an additional band with smaller Mr (V24
kDa) is present when microsomes were added indicating transami-
dase processing and GPI anchoring (C). C: mPLAP translated in
the presence of microsomes is protected from proteinase K treat-
ment. After translation in the presence or absence of microsomes,
samples were proteinase K-treated. Proteinase K was quenched by
the addition of PMSF and reactions were boiled immediately in
sample bu¡er and analysed by SDS^PAGE and autoradiography as
described in Section 2. Microsomes resulted in the protection of the
signal peptide processed mPLAP (S and W) and the formation of a
GPI-anchored species in the case of mPLAPS179. S = mPLAPS179;
W = mPLAPW179; Icons correspond to various processing forms
described in A. Molecular weight standards are indicated in kDa.
Fig. 2. mPLAPW179 is speci¢cally exported from canine micro-
somes in an ATP- and cytosol-dependent manner. After translation/
translocation of mPLAPW179 (A) or L-lactamase (B) mRNA, mi-
crosomes were reisolated and used for export. After 90 min at
32‡C, the supernatant (S) was separated from the microsomes (P)
by centrifugation and equivalent amounts analysed by SDS^PAGE.
ATP or cytosol alone had no e¡ect on the distribution of the
mPLAPW179 (A, upper two rows) whereas when added together, a
signi¢cant amount of protein was recovered in the cytosolic fraction
(S in third row from top). GTP at 10 WM has no additional e¡ect
on export when added with ATP and cytosol (bottom second row)
and did not stimulate export when added with ATP alone (bottom
row). Experiments were performed twice and done in duplicate. In
contrast, L-lactamase localisation (B) was not a¡ected by incubating
the microsomes under any conditions which allowed mPLAPW179
release (compare third rows of A and B).
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was separated from the pellet (membranes) and analysed by
SDS^PAGE (Fig. 2A). Incubating the loaded microsomes
with cytosol at 32‡C had no e¡ect on the partitioning of
mPLAPW179 as the vast majority of the protein was recov-
ered in the microsomal fraction (Fig. 2A, top row). Incuba-
tion with an ATP regenerating system (see Section 2) also had
very little e¡ect on the localisation of the mutant protein
(which remained within the microsomes). These assays also
indicate that handling of the microsomes did not cause non-
speci¢c leakage of contents. By contrast, when both ATP and
cytosol were present in the incubation reactions, a signi¢cant
amount of mPLAP (V20%) was released into the medium
indicating export from ER to cytosol (Fig. 2A, 3rd row).
Addition of GTP at 10 WM to cytosol (not shown) or to
cytosol plus ATP had no additional e¡ect on the proportion
of exported mPLAPW179 (Fig. 2A, 4th row). Signi¢cantly,
GTP did not bypass the requirement for cytosol in the pres-
ence of an ATP regenerating system for mPLAPW179 export
(Fig. 2A, bottom row) which is in contrast to glycopeptide
export [23]. Microsome latency was not compromised under
the export conditions described here as evidenced by the re-
tention of translocated L-lactamase in the microsomal fraction
after incubation with ATP, cytosol, GTP or these components
in combination (Fig. 2B).
Hence, export of mPLAPW179 from the ER can be recon-
stituted in vitro and requires the presence of both cytosol and
ATP, similar to observations for in vitro ER export of mis-
folded proteins in Saccharomyces cerevisiae [6]. Signi¢cantly,
the failure of GTP to replace cytosol is in contrast to our
recent data which demonstrate that glycopeptide export may
be reconstituted with ATP and GTP alone [23]. These obser-
vations thus indicate that glycopeptide export and misfolded
protein export are biochemically distinct and that misfolded
protein export requires additional cytosolic factors.
3.3. Export of mPLAPW179 is time-dependent
In order to con¢rm that mPLAPW179 export was physio-
logically relevant, we studied the microsome export kinetics in
the presence of ATP and cytosol. Fig. 3 shows that export
was time-dependent with about 20% of the protein exported
after 120 min. Export is linear with time and requires both
ATP and cytosol. ATP or cytosol alone control incubations
showed no signi¢cant export. These data demonstrate that
mPLAPW179 is exported in a time-dependent fashion and
also that membrane integrity was not compromised over the
120 min, con¢rming that a bona ¢de speci¢c export reaction
was reconstituted. No further export was observed after 2 h
and reached a maximum of 20%. This low e⁄ciency could be
due to a tight binding of the mPLAPW179 to molecular chap-
erones like BiP in the ER [24].
3.4. Redox does not in£uence mPLAPW179 export
Previously we have shown that redox can play a critical role
in the ability of ER to process misfolded protein. Speci¢cally,
the model GPI signal containing protein hD28 forms disul-
phide-linked homooligomers, and degradation of this protein
can be accelerated by addition of DTT, which we interpreted
as indicating that retranslocation to the cytosol requires
monomeric forms of the hD28 [25,26]. In addition, a free
cysteine in the C-terminus was found to be essential for e⁄-
Fig. 3. mPLAPW179 export from canine pancreatic microsomes is
time-dependent. Export from mPLAPW179-loaded microsomes was
performed for the speci¢ed period of time. A: Autoradiograph of
the protein recovered in the membrane (P) and cytosolic (S) frac-
tions. B: Quantitation using NIH-Image analysis of this material
relative to the total in both cytosol and membrane fractions. In the
presence of both ATP and cytosol, a time-dependent export of the
mPLAP is observed reaching about 20% after 120 min. Controls
shown are ATP or cytosol only. The experiment was repeated twice
with essentially identical results.
Fig. 4. Redox conditions have no signi¢cant e¡ect on export of
mPLAPW179 from microsomes. 5 mM DTT was added to the ex-
port reaction mix as indicated on the graph and reactions were then
incubated at 32‡C for 90 min. Reactions were split into pellet and
supernatant and analysed as in Fig. 3. Only reactions containing
both ATP and cytosol showed signi¢cant amounts of mPLAPW179
release into the supernatant. Controls (cytosol, ATP and GTP
alone) represent single data points, for full reactions error bars are
indicated (n = 2).
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cient ER retention of hD28 [8]. We chose to investigate the
in£uence of DTT of mPLAPW179 which has only two cys-
teine residues (182 and 189 of prepromPLAP) at analogous
positions within the C-terminus to the critical cysteine in
hD28 required for retention [15]. DTT at up to 5 mM in
the export assay medium had no e¡ect on the proportion of
exported mPLAPW179 (Fig. 4). Addition of DTT with both
ATP and cytosol or in the control reactions (ATP alone,
cytosol alone or GTP alone) did not increase the level of
export (compare white bars and grey bars in Fig. 4), hence
for this substrate, redox is not an important factor for re-
export.
Reconstitution of ER quality control mechanisms, and in
particular the re-export pathway for malfolded proteins, has
been achieved in S. cerevisiae, but for higher eukaryotes this
has proved more problematic. Here we report the re-export of
an mPLAP variant that is a model for GPI addition and
quality control [13]. Translocation from the microsomal lu-
men requires ATP and cytosol and is time-dependent, indicat-
ing that re-export requires energy and cytosolic factors. How-
ever, the reaction is rather ine⁄cient, with export ofV20% of
mPLAP representing the maximum we have achieved with
this system. This is in contrast to the high e⁄ciency of trans-
location into the microsomes and also of export of simpler
substrates from microsomal membranes, e.g. glycopeptides,
where we routinely achieve V80% re-export of the loaded
peptide [20,23]. This low export e⁄ciency may re£ect contin-
ued engagement with chaperones, which is not expected to
occur for the e⁄ciently exported glycopeptide substrate. The
di¡erential e⁄ciency may also re£ect speci¢c requirements for
the export route; in the case of mPLAP we expect that export
is via Sec61p, but for glycopeptide it is possible that alterna-
tive channels in the ER membrane are used [20,23]. Indeed, as
the ER is known to be functionally composed of as yet ill
de¢ned subdomains, it is possible that much of the mPLAP
translocated into the microsomal lumen is in an environment
where export cannot take place as the ER fragment is derived
from a region of the organelle devoid of essential export fac-
tors. Our data also indicate that the requirements for poly-
peptide export are more complex than for glycopeptide, as we
have recently demonstrated that cytosolic proteins are not
required for the latter substrate [23]. This may re£ect the
need to direct polypeptides e⁄ciently into the cytosolic pro-
teasome as they emerge from the translocon. The system de-
scribed here should provide a vital tool for the identi¢cation
of such factors.
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